Analysis of Methyldopa Therapy on sFlt-1 Antiangiogenic Levels in Patients with Severe Preeclampsia

Analysis of Methyldopa Therapy on sFlt-1 Antiangiogenic Levels in Patients with Severe Preeclampsia

Methyldopa is the first-line drugs to treat hypertension in pregnancy. It can decrease blood pressure in preeclampsia by affecting a2-adrenoreceptors in central nervous system. However, it could also act by decreasing  production of sFlt-1 antiangiogenic protein levels involved in the pathophysiolog...

Full description

Bibliographic Details
Main Authors: Teri Wina Herwati, Yulistiani Yulistiani, Eddy Zarkaty M
Format: Article
Language:English
Published: Universitas Airlangga 2018-04-01
Series:Folia Medica Indonesiana
Subjects:
Methyldopa
severe preeclampsia
antiangiogenic
soluble fms-like tyrosine kinase (sFlt-1)
Online Access:https://e-journal.unair.ac.id/FMI/article/view/8052

Similar Items

Similar Items